Chinook Therapeutics, Inc. Profile Avatar - Palmy Investing

Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin recepto…

Biotechnology
US, Seattle [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of KDNY's Analysis
CIK: 1435049 CUSIP: 16961L106 ISIN: US00739L1017 LEI: - UEI: -
Secondary Listings
KDNY has no secondary listings inside our databases.